Exertion-Triggered Headache - Clinical Analysis

Diagnostic Approach: New vs. Old Headache

The "Must Not Miss" Diagnoses First

1. Subarachnoid Hemorrhage (SAH) - Highest Priority

"Onset of thunderclap headache during periods of exertion raises suspicion for subarachnoid hemorrhage or arterial dissection of the carotid or vertebrobasilar circulation."

• Age ≥40 years
• Neck pain or stiffness
• Witnessed loss of consciousness
• Onset during exertion ✓ (present in this case)
• Thunderclap headache (peak pain within 1 second)
• Limited neck flexion on examination

2. Reversible Cerebral Vasoconstriction Syndrome (RCVS)

3. Arterial Dissection

Primary (Benign) Diagnoses - After Excluding Dangerous Causes

4. Primary Exertional Headache (Benign Exertional Headache)

"A patient may complain of very severe, transient cranial pain on coughing, sneezing, laughing heartily, lifting heavy objects, stooping, and straining at stool... The pain is often described as having a bursting quality... Most often this syndrome is a benign idiopathic state that recurs over a period of several months to a year or two and then disappears."

5. Migraine Triggered by Exertion

The Position-Change Worsening - An Important Clue

• Raised intracranial pressure - from any space-occupying lesion, hemorrhage, or CSF outflow obstruction
• Colloid cyst of the third ventricle - classically causes positional headache and can present acutely
• Cerebral venous sinus thrombosis - another exertional/positional headache entity

Red Flag Summary ("SNOOP4" Features Present)

Recommended Workup

1. Noncontrast head CT - immediately, to exclude hemorrhage
2. LP with xanthochromia assessment - if CT is negative but suspicion for SAH remains (CT misses ~2% of SAHs at 6 hours, more at later presentation)
3. CT angiography or MR angiography - to evaluate for aneurysm, arterial dissection, RCVS, or venous sinus thrombosis
4. Blood pressure measurement - malignant hypertension can also cause exertional pulsating headache

Important note: This analysis is for educational purposes. A new severe exertional headache with positional aggravation requires in-person medical evaluation - ideally in an emergency setting - to rule out hemorrhagic and vascular causes before any diagnosis of a benign primary headache disorder can be made.

Cutaneous Allodynia - What Your Symptom Means

"The allodynic migraineur experiences pain or discomfort with normally nonnoxious stimulation of the skin, such as occurs with light touch of the face or scalp, wearing eyeglasses, shaving the face, and wearing a tight collar or necklace."

Why This Happens - Central Sensitization

What This Tells Us Diagnostically

• Cutaneous allodynia develops in approximately two-thirds of migraineurs during an attack - it is one of the most characteristic features of migraine pathophysiology
• Combined with your earlier symptoms - throbbing/pulsating quality, gradually progressive intensity, holocephalic distribution, worsening with movement/position change, and exertional trigger - the allodynia rounds out a picture very consistent with migraine
• The scalp vessels themselves can become distended and tender during a migraine attack, which further explains the touch-sensitivity

1. Treatment timing is critical. The presence of allodynia during an attack predicts a less robust response to acute treatments (like triptans). Triptans work best when taken early in the attack - before central sensitization sets in. Once allodynia is present, the window for optimal acute treatment may have partially closed.
2. Risk of chronification. A history of allodynia increases the risk of migraine becoming chronic (more than 15 headache days per month). This is a flag to discuss with a neurologist.
3. Treatment implication. If attacks with allodynia become frequent, onabotulinumtoxinA (Botox) for chronic migraine has actually shown a more favorable response in allodynic migraineurs specifically.

Does This Change the "Must Not Miss" Picture?

• Bradley and Daroff's Neurology in Clinical Practice
• Adams and Victor's Principles of Neurology, 12th Ed.

Migraine Treatment: Acute Episode + Prevention

Part 1: Treating This Episode (Acute/Abortive Treatment)

Step-Up Strategy

Mild-to-Moderate Attack: Non-Specific Analgesics First

Moderate-to-Severe Attack: Triptans (First-Line Specific Therapy)

• Rizatriptan and eletriptan are the most effective on a population basis
• Faster onset = better effect: sumatriptan SC (onset ~20 min) beats oral (1-2 hours); clinical efficacy relates more to time-to-peak plasma level than potency
• Adding naproxen 500 mg to sumatriptan both augments the initial effect AND significantly reduces headache recurrence - this combination is well-supported by RCT evidence
• Do not use triptans in patients with ischemic cardiac, cerebrovascular, or peripheral vascular disease (they are vasoconstrictors)
• If one triptan fails, try a different one - individual responses vary considerably

What About the Allodynia/Timing Problem?

• Subcutaneous sumatriptan (SC) is preferred - it bypasses gastric stasis (which also occurs during migraine) and achieves peak levels in ~12 minutes
• Nasal sumatriptan or zolmitriptan are the next-best non-oral options

If Triptans are Contraindicated or Unavailable: Alternatives

• Lasmiditan (ditan, 5-HT1F agonist) - does NOT cause vasoconstriction, so safe in cardiovascular disease; classified as a controlled substance; do not drive after taking it
• Gepants (CGRP receptor antagonists):
  • Ubrogepant or Rimegepant - oral, for acute treatment; no vasoconstriction; safe with cardiovascular risk factors
  • Rimegepant can also serve double-duty for prevention

Antiemetics

• Prochlorperazine - both controls nausea and has independent analgesic properties in migraine
• Metoclopramide - also helps with gastric stasis, improving absorption of oral medications

Ergot Alkaloids (Older Agents)

Non-Pharmacological Measures During an Attack

• Lie in a dark, quiet room (photophobia and phonophobia are expected)
• Cold or warm compress on the forehead/scalp (whichever is more comfortable)
• Hydration
• Sleep, if possible - migraine often resolves after sleep

Part 2: Preventing Future Episodes

Indications to Start Prevention

• ≥2 attacks/month that impair daily function
• Attacks lasting >48 hours
• Rescue medications needed >2 days/week (risk of medication-overuse headache)
• Presence of allodynia (risk of chronification)
• Attacks triggered predictably by exertion (as in this case - prophylaxis before exercise is a specific strategy)

First-Line Preventive Agents

1. Beta-Blockers (Drugs of Choice)

• Propranolol: 40-240 mg/day (divided doses)
• Especially relevant here: for exertional migraine, propranolol taken before exercise has direct clinical evidence of preventing attacks (as noted in Symptom to Diagnosis for the clinical case of exertional headache treated with pre-exercise propranolol)
• Avoid in asthma, severe bradycardia, or depression

2. Anticonvulsants

• Topiramate (25-200 mg/day) - Level A evidence; also causes weight loss (useful if weight is a trigger); can cause cognitive slowing ("dopamax" effect) and kidney stones
• Valproate/Divalproex (500-1500 mg/day) - effective; avoid in women of childbearing age (teratogenic); causes weight gain

3. Antidepressants

• Amitriptyline (10-150 mg nightly) - tricyclic; works independently of mood effect; sedating at night (beneficial for sleep disruption in migraine); also treats comorbid depression and tension-type headache
• Venlafaxine (SNRI) - evidence for migraine prevention, better tolerated than amitriptyline

4. Calcium Channel Blockers

• Verapamil - moderate evidence; useful if beta-blockers are contraindicated

Newer/Specialized Preventive Agents

5. CGRP Monoclonal Antibodies (Injectable, Monthly or Quarterly)

6. OnabotulinumtoxinA (Botox)

• Approved specifically for chronic migraine (≥15 headache days/month)
• 155 units injected across 31 sites on the head and neck, every 12 weeks
• Particularly effective in patients with allodynia - which this patient has
• Not useful for episodic migraine (fewer than 15 days/month)

7. Oral CGRP Antagonists for Prevention

• Rimegepant (75 mg every other day) and atogepant - dual-use: acute treatment AND prevention

Lifestyle and Trigger Management (Non-Pharmacological Prevention)

Summary Decision Framework

Acute attack:
  Mild     → NSAID (ibuprofen/naproxen ± caffeine)
  Moderate → Triptan (rizatriptan or eletriptan oral) + naproxen
  Severe   → Sumatriptan SC or DHE nasal/injection
  Allodynia present → prefer SC/nasal route; add antiemetic
  CV contraindication → gepant (ubrogepant/rimegepant) or lasmiditan

Prevention:
  First-line    → Propranolol or topiramate or amitriptyline
  Exertional    → Pre-exercise propranolol specifically
  Refractory    → CGRP monoclonal antibody
  Chronic (≥15d/mo) → OnabotulinumtoxinA ± CGRP mAb

Does Paracetamol Response Tell Us the Etiology?

"Improvement of the patient's pain with treatment does not predict benign cause of headache."

Why Response to Paracetamol is Misleading

1. Serious Causes Can Respond to Paracetamol

• Activating descending serotonergic pain-modulation pathways in the CNS
• Inhibiting prostaglandin synthesis centrally

2. Migraine Can Fail to Respond to Paracetamol

"Failed NSAIDs/analgesics → First tier: Sumatriptan 50-100 mg"

Where Analgesic Response Has Some (Limited) Signal

The Practical Conclusion

• If paracetamol relieves it: This does not rule out SAH, RCVS, or any vascular cause. It also does not confirm migraine.
• If paracetamol does not relieve it: This does not rule in a serious cause. Given the already-established allodynia (central sensitization), a partial or absent paracetamol response is actually the expected pattern in migraine at this stage of the attack.

The bottom line: Paracetamol response is diagnostically neutral. Never use it to reassure yourself or the patient that a headache is benign.

• Tintinalli's Emergency Medicine: A Comprehensive Study Guide
• Lippincott Illustrated Reviews: Pharmacology
• Harrison's Principles of Internal Medicine 22nd Ed.